Free Newsletter
Contract manufacturing to see double-digit growth
Hold onto your hats: The global market for contract manufacturing is headed for speedy growth over the next few years. According to a new report from RNCOS, pharmaceutical contract manufacturing is poised to grow about 12 percent per year from 2010 to 2012.
Cost is one of the reasons, of course. Another is the fact that CMOs have built up a lot of manufacturing infrastructure, making more contract work possible. Then there's some companies' new business strategy: the "virtual pharma" that holds marketing rights to a product, but outsources production and the like.
Just where is that CMO business going? According to RNCOS, leading destinations are India, Brazil, Ukraine, Mexico, China and Singapore.
- see the RNCOS release
Related Articles:
CMOs poised for biologics domination
New companies flooding CMO market
Pharma feeds contract manufacturing
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: